All information is correct at time of printing and is subject to change without notice. The Devon Formulary and Referral Website is not in any way liable for the accuracy of any information printed and stored by users. For the most up-to-date information, please refer to the website.
Following a review of the effectiveness of current measures to reduce the risk of potentially long-term or irreversible side effects associated with fluoroquinolone antibiotics, the MHRA introduced further restrictions to limit fluoroquinolone use. The MHRA announced that fluoroquinolone antibiotics given systemically (by mouth, injection, or inhalation) must only be administered when no other antibiotics are appropriate for use.
The Devon Formulary has been updated to include the strengthened regulations from the MHRA and fluoroquinolones are now only to be used when other recommended antibiotics have failed, will not work due to resistance, or are unsafe to use in an individual patient.
See here for the drug page.
See here for other recent updates to the formulary.